LenioBio
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Erkrather St 401, Düsseldorf, Nordrhein-...Phone Number
+49 211890940300Website
www.leniobio.comRevenue
$6.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About LenioBio
LenioBio GmbH is a protein expression platform company committed to the advancement of transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell. LenioBio was established as a legal entity in Germany in September 2016, with offices in Dusseldorf and R&D and production labs in Aachen.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LenioBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if LenioBio has recently received funding, and reach out quickly before it becomes old news!
LenioBio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if LenioBio is spiking on competitors!
Click to see if LenioBio had a recent Job posting/layoffs
Product Launch: Get notified when LenioBio launches new products
Earning: See what the market has to say on LenioBio recently announced quarterly report
Funding: Get notified immidiatlly once LenioBio has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at LenioBio
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
LenioBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LenioBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LenioBio.
LenioBio financials insights
Gather financial insights about LenioBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$12.5M
2023
Grant
$1.9M
2025
Grant
$4.3M
LenioBio Tech Stack
A closer look at the technologies used by LenioBio
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Funding
Funding
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Award, Video
Event
Events
LenioBio News & Media
LenioBio partners with AffinityAI to accelerate discovery of novel complex proteins through AI-guided design and high-throughput cell-free expression
DÜSSELDORF, Germany, Sept. 3, 2025 /PRNewswire/ -- LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration combines LenioBio's proprietary cell-free protein expression platform, ALiCE®, with...LenioBio secures EUR 3.7M of EU4Health funding to develop ALiCE® for cost-effective and rapid production of protein-based medicines
DÜSSELDORF, Germany, July 23, 2025 /PRNewswire/ -- LenioBio GmbH has been awarded EU4Health funding by the European Health and Digital Executive Agency (HaDEA), which implemented the corresponding call for proposals on behalf of the European Commission's Health Emergency Preparedness and...LenioBio Earns Prestigious EU STEP Seal: A Signal of Excellence for Investors
DÜSSELDORF, Germany, March 13, 2025 /PRNewswire/ -- LenioBio is proud to announce that it has been awarded the prestigious STEP Seal by the European Commission as part of its submission to the EU4Health funding call. The STEP Seal—standing for Strategic Technologies for Europe Platform—is...LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and Expedite Vaccine Production
Advancing CEPI's 100 Days Mission to Accelerate Vaccine Development DUSSELDORF, Germany, Oct. 2, 2024 /PRNewswire/ -- LenioBio, the leader in rapid cell-free protein expression technologies, is pleased to announce a collaboration with ReciBioPharm, a global contract development and...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LenioBio
Sign Up For FreeTo access detailed company insights
LenioBio GmbH is a protein expression platform company committed to the advancement of transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell. LenioBio was established as a legal entity in Germany in September 2016, with offices in Dusseldorf and R&D and product... Read More
